Showing 3581-3590 of 18631 results for "".
Beyond Durability - What Biomarkers Reveal About Disease Control
https://reachmd.com/programs/cme/Beyond-Durability-What-Biomarkers-Reveal-About-Disease-Control-2510/33104/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.Five Strategies to Attract the Right Clientele
https://modernaesthetics.com/topics/practice-development/five-strategies-to-attract-the-right-clientele/35153/Tips for bringing attention to your aesthetics practicePredicting Breast Cancer Metastasis with Proteomics
https://reachmd.com/programs/project-oncology/predicting-breast-cancer-metastasis-with-proteomics/49189/The Genetic Counselor
https://reachmd.com/programs/advances-in-womens-health/the-genetic-counselor/1988/The Genetic Counselor as an amazing tool in your medical armamentarium: As the genome becomes better understood new medical challenges will become evident. The tools to best educate ourselves and to assist our patients as they need to determine the w’s: when, who and why should someone undergo geneEffective Monitoring and Management of Adverse Effects in Metastatic ESCC
https://reachmd.com/programs/cme/effective-monitoring-and-management-of-adverse-effects-in-metastatic-escc/29792/Explore emerging data, guideline recommendations, and AE management for first-line anti-PD-1 and chemotherapy regimens in metastatic ESCC.Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
https://reachmd.com/programs/cme/strategies-for-navigating-first-line-treatment-selection-in-metastatic-escc/33029/Explore emerging data, guideline recommendations, and AE management for first-line anti-PD-1 and chemotherapy regimens in metastatic ESCC.HER2-Expressing MBC In Depth: The Latest Advances in Targeted Therapies and Brain Metastases Management
https://reachmd.com/programs/cme/her2-expressing-mbc-in-depth-the-latest-advances-in-targeted-therapies-and-brain-metastases-management/29733/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
https://reachmd.com/programs/cme/distinguishing-between-anti-pd-1-agents-in-escc-combination-therapies/29790/Explore emerging data, guideline recommendations, and AE management for first-line anti-PD-1 and chemotherapy regimens in metastatic ESCC.PRP Scaffolds in Chronic Wound Care: A Move Toward Regenerative Solutions
https://reachmd.com/programs/clinicians-roundtable/prp-scaffolds-in-chronic-wound-care-a-move-toward-regenerative-solutions/36422/Building a Culture of Compliance in Contact Lens Care
https://reachmd.com/programs/modern-optometry/building-a-culture-of-compliance-in-contact-lens-care/39995/